CAR-T Cell Therapy in India for Kenyan Patients

CAR-T Cell Therapy in India for Kenyan Patients offers a revolutionary, low-cost solution for treating relapsed blood cancers. Utilizing indigenous breakthroughs like NexCAR19, top-tier institutions such as Apollo Cancer Centres and Fortis Memorial provide treatment at a fraction of Western costs. Kenyan patients benefit from comprehensive medical visa support, advanced ICU monitoring for safety, and specialized international desks. This cutting-edge immunotherapy provides a vital second chance with high clinical success rates and personalized care protocols.